Boai NKY Medical Holdings Ltd. (SHE:300109)

China flag China · Delayed Price · Currency is CNY
18.93
+0.27 (1.45%)
Apr 29, 2026, 3:04 PM CST
30.37%
Market Cap 9.15B
Revenue (ttm) 1.18B
Net Income (ttm) 190.09M
Shares Out 483.38M
EPS (ttm) 0.39
PE Ratio 48.54
Forward PE n/a
Dividend 0.25 (1.34%)
Ex-Dividend Date Jul 10, 2025
Volume 9,597,719
Average Volume 10,654,663
Open 18.71
Previous Close 18.66
Day's Range 18.28 - 18.99
52-Week Range 14.50 - 21.11
Beta 0.18
RSI 54.87
Earnings Date Apr 24, 2026

About Boai NKY Medical Holdings

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, oral care, and household care; alcohol, soft drinks, and food; battery, petroleum and natural gas, and photovoltaic; and membrane, textile and dyeing, ag... [Read more]

Sector Materials
Founded 1987
Employees 1,163
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300109
Full Company Profile

Financial Performance

In 2025, Boai NKY Medical Holdings's revenue was 1.18 billion, a decrease of -26.66% compared to the previous year's 1.61 billion. Earnings were 190.09 million, a decrease of -45.64%.

Financial Statements

News

There is no news available yet.